Getting older without getting old - with Andrew Steele

HealthCare Advices
217 followers
451 Video Views·Jan 9, 2023
Hello everybody, good evening, thanks so much for coming along and hello to everyone who's
watching online, who I gather there's quite a lot of you. I'm Andrew and I want to tell you about
what I think is the most exciting and consequential science of our time. You can see that my talk is
named after my book, it's Ageless, the new science of getting older without getting old. And I want
to show you some of this new science and show you how I think it literally could make human
beings ageless eventually. And I also think we need to answer the question of, you know,
would we actually want to do that? I want to change the way that you think about ageing,
because I think a lot of us think of ageing as sort of a natural part of being alive. As you
get older you notice that your grandparents, then your parents, then your friends and yourself start
to age, you get wrinkles, you get grey hair. Obviously not everything about the ageing process
is bad, you acquire wisdom and experience during that time as well. But I think that ageing is our
greatest humanitarian challenge, and that might sound like a slightly weird thing to say, so I'm
going to unpack that a bit during the first part of the talk. I think a lot of us also think that
ageing is inevitable. You know, we see it happen to the people around us, but it also happens to
animals, it happens to our pets, our cats, our dogs, our mice, our hamsters. It happens at very
different rates in different species, but actually if you've ever watched a pet get old, they tend to
get old in a very similar way to the way that humans do. So is this just some sort of biologically
universal sort of process of falling apart that we really can't do much about? Well actually the
answer to that is no, because what this new science shows us is that the ageing process is malleable,
it's plastic, it's surprisingly controllable in the lab. We've got literally dozens of ways to slow
down and even reverse this process, and some of these are making their first baby steps out of the
lab into actual human clinical trials. This is a really, really exciting time, and I think that's
the sort of the combination that makes this such a fascinating field for me, because on the one
hand we've got this world's greatest humanitarian challenge, a genuine huge problem for us to try
and rise to, but then on the other side of the coin we've got this enormous scientific potential, the
ability to rise to that challenge. So I just think this is utterly fascinating, and I hope that I'll
convince you all of that during the course of the evening. But where I'd like to start is right back
at the beginning, and actually back at the beginning of my career as a computational biologist. So as
you heard, I actually didn't start out as a biologist, I did a degree and even got as far as
finishing a PhD in physics before deciding that ageing was this single most important problem that
we needed to do something about. And actually maybe this is because of my physics training, I'm very
sort of numerical and stats driven, more than, you know, some people ask me if I've had some terrible
experience with death in my youth or something like that, and that's what drew me into it. But
actually I changed career because of a graph. So I'd like to show you that graph and show you that
although it's a very simple graph, its implications are absolutely enormous. So the graph looks
something like this. Up here you can see that along the bottom you've got how old you are in years,
and up the side you've got your chance of death in that year. Now I think all of us know that older
people are more likely to die, but just how much really shocked me. So the line looks something
like this. Let me try and explain that by sort of going through it from left to right. When you're
born that year is actually quite a risky year for people, even this is a graph for people who are
lucky enough to live in the rich world, but even in a developed country you've got something like a
half a percent chance of not making it to your first birthday. And that's obviously because you
could be born with some kind of congenital problem, a genetic defect, maybe you get cancer or an
infection very early in your life. But if you make it to your first birthday actually things keep on
getting better and better for quite a few years until you reach the age of 10. And current 10
year olds have an incredible title, they are the safest humans in the history of our species. So if
you've got any 10 year old you know sons or daughters or cousins let them know this amazing
fact, because they've got a less than one in 10,000 chance of not making their 11th birthday.
Now unfortunately it's all downhill, or rather on this graph uphill from there. So if you're 18 you've
got about a one in three thousand chance of dying that year. I'm 36, that means my odds of dying are
about one in a thousand this year. And it's worth just stopping and thinking about that for a moment
because I quite like those odds. If that were to continue for the rest of my life I'd live another
thousand years on average, I'd make it into my thousand and thirties. So clearly that isn't what
goes on. Actually what happens is that after you reach the sort of age of 20 or 25 humans risk of
death doubles every eight years. This is something that we call the mortality rate doubling time, the
time it takes for your risk of death to multiply by two. And if you start off with something that's
quite a small number like one in a thousand you can double it a fair few times before it starts
getting scary. So if you're 65 your risk of death is about one percent that year. Still not too bad,
if that were to continue you'd still make it into your 160s. But unfortunately one percent is now a
big enough number that when you start doubling it, you know, serious things can start to happen.
If you're 80 you've got about a one in 20, so a five percent chance of death that year.
And if I'm lucky enough to live into my 90s and medical technology doesn't advance at all in the
intervening time, I'll be somewhere way off the top of this graph, my odds of death in the early years
of my 90s will be about one in six. So it's life and death at the roll of a dice. These are odds I
particularly want to run. And so you can look at this graph in a couple of different ways. You can
look at it as a human and you can think, my god, that's terrifying. I've got this enormous wall of
exponentially increasing mortality coming at me. Or you can look at it as a physicist and you can
say, gosh, this is actually really fascinating. What is it about human biology that means we have
this astonishingly synchronized increase in all kinds of things going wrong with our bodies at
the same time? And this is a really, really universal phenomenon. If I were to go back to
the 1600s or if I were to go exploring in the Amazon rainforest and find some undiscovered tribe,
their absolute risk of death might be quite a lot higher, so they have a shorter life expectancy.
But they would have that same eight-year mortality rate doubling time. This seems to be an intrinsic
fact about being human. And so you've got to wonder, what is it that's going on in our biology
that makes us so much more likely to die as we get older? What is this universal ticking clock in all
of us? And most excitingly, could we identify this ticking clock and could we do something about it?
So that means in order to answer that question, we're going to have to ask another question.
And that question is, what is ageing? And there are a few different ideas that I'm going to come
up with on this slide. The first is the obvious one. I've already mentioned it. I think it's the
first thing most people think of when you mention ageing to them. It's the cosmetic external stuff,
the wrinkles and the grey hair. And while these can be distressing for some people, as a biologist
and want to be a helper of the world through medicine, these aren't the things that concern
me the most. The most concerning things are what are called the age-related diseases. These are
diseases like cancer and heart disease, dementia, stroke, diseases that are substantially more
likely as you get older. You can do things that increase your risk of these things. You can smoke
and increase your risk of lung cancer, for example. But ultimately, the single biggest risk factor for
all of these, that's sort of medical jargon, is just how long ago you were born. It's being an
older person. Then there's the stuff that sometimes gets you a medical diagnosis, sometimes doesn't.
And I've sort of grouped these together into a category. Overall, it's loss. It's loss of your
vision, your hearing, your memory, your muscles, all of these different things. And, you know,
as I say, sometimes this will be enough for a medical diagnosis. Sometimes it won't. It's just
a sort of problem that you have to live with. And overall, this category is sort of loss of
independence. It means you can't do the stuff you want to do. You can't play with your grandkids.
You can't get up the stairs. You can't get around the house. You can't do your hobbies. You can't
eventually do everyday tasks. So that's the thing that I think ageing really sucks from all of us,
ultimately. And finally, we've got the stuff that isn't strictly ageing-related per se,
but is much, much more serious as you get older. So these are things like infections and injuries,
things that, you know, a younger person would basically just shrug off. You know, imagine if
I broke a bone. I'd probably just end up having a plaster cast on for a few weeks and basically
being fine. But if a 70 or 80-year-old breaks their bone, they often break their hip, they go
into hospital. It's a very serious thing. They can be in a hospital bed for a few weeks and lose a
load of muscle mass. They might contract a hospital-acquired infection. And ultimately,
something like breaking a hip can begin a spiral that ultimately goes on to end their life.
So this is something that's much, much more serious as you get older.
And to go back to my favourite graph, I guess. So this, now we understand, you know, behind this,
you might not be worried about dying itself because, you know, maybe there's just nowhere
you go and there's no particular pain on your part. But what this really represents is a huge
increase in the risk of all different kinds of suffering. So I'm going to slightly change the
graph. Still got your ageing years along the bottom, but up the side, we've got your chance
of being diagnosed with a particular illness. And we can look at cancer, heart disease, stroke,
dementia. And what you can see is they all follow slightly different patterns. But broadly speaking,
it's the same thing. It's this exponential increase with age. Actually, dementia is
particularly terrifying. Almost unheard of before the age of 60, unless you have a genetic
predisposition to it. But after the age of 60, the risk of dementia doubles every four and a half
years. So dramatically faster than the risk of death itself. And obviously, dementia is a disease
that a lot of us are rightly very scared of. So these are the sort of strictly age-related things.
To add another one, this disgusting mucousy green line here represents chest infections. This isn't
just a little sort of cough or sneeze or a cold. This is a proper thing that gets right, everyone
in the audience now coughing, some kind of reflexive reaction. This isn't just a little
cough. It's something that gets right down into your chest, really, really quite unpleasant.
What you can see is that even in your sort of young middle age, when your chances are lowest,
you've still got a 1% or 2% chance per year of getting a chest infection. But when you're young
or when you're old, what that means is either you've got a naive underdeveloped immune system
or your immune system is starting to weaken because of the ageing process. You're much,
much more likely to get one of these diseases. And the worst thing is that at the end of life,
obviously, you're much, much more likely to die from it as well. And there is one disease,
of course, one respiratory infection, in fact, that can't really go without mentioning,
even though we're all trying to forget about it. This is your chance of death if infected
from coronavirus. And it looks something like this. Again, sort of boringly familiar by this
point. It's another exponentially increasing graph. Your risk of death from coronavirus
doubles about every six and a half years. And that means that if you're 80 and you catch
coronavirus, you are literally hundreds of times more likely to die than someone who's 30 and
catches that same disease. Now, the good news is I hope most people in this room have been
vaccinated. And that means that curve has shifted quite a long way to the right. It effectively
takes 20 or 30 COVID years off your age. And that means you're much, much more likely to survive,
much more likely not to end up in hospital as a result of that. But nonetheless, it's still
much riskier to be an old person, even if you're triple vaccinated, compared to a younger person
who catches COVID. There's still this enormous exponential increase in risk with age. And so,
you know, what it just makes me think is ageing has this enormous potential. And sort of to skip
ahead a little bit, imagine if we could come up with a treatment that could reduce the age of
your immune system by 10 years. And imagine we could give that to everyone in the population.
We could have that ready for the next pandemic. That's the ultimate protection against almost any
virus that might appear, or almost any other kind of pandemic infection, because we'd all just have
a much stronger reserve, much stronger defences to try and fight that virus off. So, to return to
this, I think what this graph really does is it explodes a myth. And that myth is that you can
die of old age. You used to be able to write that on a death certificate, but it's no longer allowed,
because actually most people die of something quite specific. And most of these diseases, I'm sure all
of you have friends or relatives who've had one of these things. They're not necessarily a painless
way to go. You don't just fall asleep and not wake up the next morning. Cancer can have years of
gruelling chemo and radiotherapy. Heart disease slowly, you know, robs your ability to get around,
might stop you getting up the stairs, and eventually, you know, you're hardly able to move at all as a
result of your weakened heart. So, all of these things have huge, huge social and individual and
sort of moral consequences. So, this is why I think that ageing is our greatest humanitarian
challenge, because behind those death statistics, even if you're sort of unworried about the death
itself, are years, perhaps even decades of suffering that come before that. So, you might be
thinking, Andrew, you know, maybe this is a problem that we in the rich world are lucky enough to have.
This is something that, you know, we're sort of perversely lucky in that we live long enough to
experience some of these conditions. And what I'm going to do now is I'm going to do a quiz. So, I'd
like everyone who's physically in person to stand up for me. So, please get out of your seats. Everyone
on the live stream, you're going to have to just think about this at home. So, I want you to imagine,
the quiz question is, what is global life expectancy? How many years does the average
person on planet Earth live? So, not just in the rich countries, but all around the world. And what
I'm going to do is I'm going to flash some numbers up on the graph. And this is a free starter.
Nobody sit down now, because if you thought that global life expectancy was 40 years or below,
you would sit down now. Good. No extreme pessimists in the audience. And what I'm going to do is I'm
going to keep on incrementing that up. When you think I've gone past global life expectancy,
please sit down for me. So, 50 years, any takers? Remember, this is all the countries, not just
lovely posh ones like the UK. Anyone for 60 years? Got a few? So, I'd say maybe a third
of the audience has sat down now, for those watching online. Anyone for 65 years? Got a few
more? This is like a really grim auction. Sorry. Anyone for 70 years? We've got most people sat
down now. There's still a few sort of diehards, probably the wrong word. We've got some optimists
in the audience. Anyone for 75 years? This guy. 80 years? No, even he's had it now. And just for free,
85 years is not the answer. The UK life expectancy, by the way, is about 80. This chap is going for
broke. I'm afraid that's the last one, so you're going to have to sit down, sir. The actual answer,
drumroll please, and I'm afraid most of you got it wrong, is 72.6 years. This is back in 2019.
Obviously, things have had a bit of a rough couple of years in terms of global life expectancy, and
the statistics are still coming in. What this means is most of you got it wrong. And actually, you
know, you shouldn't feel bad. You shouldn't be too hard on yourselves. If you present this as a
multiple choice question, only about 30% of people get it right. And if you present it as a multiple
choice question to university students, only about 20% of them get it right. So, education clearly
leaves something to be desired. I think what that really shows us is that we've all got this picture
of a sort of vast developing world where things are much, much poorer. There's much worse
sanitation. There's much worse access to food, that kind of stuff. We imagine that they're all,
you know, these countries have much, much lower life expectancies than ours do. But actually,
there's been a huge success story in the last 50 years of countries rapidly, rapidly catching up
with the rich world. The world leader is Japan, which has something like 85 years of life expectancy.
Here in the UK, it's about 80. A country like India, you might think, has a very low life
expectancy. It's actually 69 years now. So, these people in poorer countries really are living an
incredibly long time. We've done very well conquering things like infectious disease in
those countries. Now, the good news is that means that most people in most countries are living
longer, healthier lives than ever before. And I honestly think this is probably the greatest
achievement of, you know, in human history. But the flip side of it is that if we go back to my
favourite graph, with apologies, then most people in most countries are living long enough to
experience significant effects of ageing. They're climbing a fairly long way up that curve. And
obviously, this problem is only increasing as the global population ages. So, if we try and
translate that into what it actually means from a global statistical point of view, every single
person on this image is 1,000 deaths per day. So, 150,000 people die every single day on planet
Earth. And of those deaths, over 100,000, so more than two thirds, are deaths due to ageing. And
that's because they're deaths from cancer, heart disease, dementia, all of these diseases that
are excess deaths due to something like COVID, which isn't caused by ageing per se, but is
made worse by it, and so on. And that means that ageing is by far, you know, even if you get all
of the other causes of death, add them together and double it, you still won't get as many people
as die of ageing. So, it's by far the leading cause of death. Those deaths, as I've sort of
explained, are already preceded by this huge amount of suffering. So, you know, that's why
I think it's our greatest humanitarian challenge. And this could therefore be a very depressing talk
and a very depressing book. But luckily, we can now come to what we might be able to do about it.
And I'm sorry, this is the very last time I'm going to show you the graph that changed my career.
So, humans' risk of death doubles about every eight years I already mentioned. But what we can
do is look around the animal kingdom and see if we can find any examples of creatures that don't
have this same fate. And this is one of my favourite examples. It's a beautiful little
freshwater creature called a hydra. It's about a centimetre long, so that's a sort of mildly
magnified microscope image of it. And these things, they first came to the attention of science
because they've got incredible regenerative capacity. So, you can chop basically any bit you
like off a hydra and you'll end up with two hydra. You know, the first hydra will heal itself and the
second bit will turn into a whole new hydra. They've even done experiments where they put a
bunch of hydra in a blender and they end up with a load more hydra, basically. They've got incredible
power. But the other thing that the scientists noticed while they were doing all these slightly
crazy regeneration experiments is just how long these guys live. And actually, their risk of death
with time looks something like this. So, their risk of death is about 0.2% per year. And that means
if you do the maths, we've not actually done the experiment because we haven't had long enough to
actually test this out, but we think that about 10% of those hydra would still be alive after a thousand
years. Now, what's more amazing to a scientist than just how long they live is how flat this line is.
That line, as far as we know, doesn't change depending on how long ago they were born. And so,
hydra have a property that we call negligible senescence. Negligible, not much. Senescence,
just the scientific word for ageing. It means that their risk of death doesn't change with time.
And that's really incredible because what this shows us is, you know, although we may age and
our pets may age and so on, ageing isn't an iron law of biology. There are animals that literally
don't age by this statistical definition. And so, the question is, you know, how can we become a bit
more hydra? How can we perhaps not get all the way to having a 0.2% risk of death per year,
but how can we flatten that curve, as was a fashionable thing to say about 12 months ago,
and become a little bit more hydra, a little bit closer to negligible senescence? Well,
you might be thinking, Andrew, you know, come on, this hydra, it's a centimetre-long freshwater
creature. It's got, you know, a handful of cells in it. I'm 37 trillion cells. I'm much more
complicated than that. We can't possibly learn anything from those. Well, how about this beautiful
creature? The reason that this graces the cover of the hardback version of my book is that this
is a Galapagos tortoise. Their lifespan, the oldest one recorded, we think, was about 177
years old, or a bit uncertain, but it was brought back, we think, by Charles Darwin on his expedition
to the Galapagos, and it survived Darwin by over a century. But what's more amazing than tortoises'
long lifespan is that, again, they're negligibly senescent. It's also sometimes called something,
which is a little bit more beguiling, called biological immortality. It's not real immortality,
because you can still die, but what happens is that, because their risk of death is constant
with time, they often die much, much later. So Harriet the tortoise, who was the longest ever
recorded, she died of a heart attack, but she did so at 177, rather than 77, like a human might.
And what's most exciting is, when you've got an animal on the scale of a tortoise, you can see
whether or not it gets old in the ways that we might understand it. So we now know that tortoises
don't get any more frail as they get older. They even remain fertile until very, very late in their
lives. They've got all these different properties that seem to just be entirely maintained. They're
not at any increased risk of disease. They're still zooming around about as fast as a tortoise does,
the same as at age 150 as they were at age 50. So that's an animal that's much, much closer to us,
much, much more similar to our biology. And then if you want to come even closer to humans
evolutionarily, this beautiful creature, you might be thinking, Andrew, that's a penis with teeth.
It's actually a creature called a naked mole rat. These things live to about 31 years. That's the
longest ever recorded. They do live 25 to 30 years normally. And that's a really incredible age.
Although that thing looks very wrinkly, these two are negligibly senescent. They don't appear to
have an increased risk of death or an increased risk of disease as they get older. They're just
born looking like that because they have to squeeze past each other in tiny little burrows, and that
saggy skin really helps with that. They also seem to be protected from all kinds of age-related
diseases. They're protected from dementia. They're protected from cancer. So they really do seem to,
until the very, very last moments of their life, get older without getting old. And these creatures,
they're very closely related to mice. And mice only live two or three years, even in the lab,
perhaps only six months to a year in the wild. So these things live an incredibly long time.
They also do that with this negligible senescence property. And what this really shows us is I
actually think there are probably loads more negligibly senescent creatures out there. It's
just that the ecology, the sort of hard work of going out and tagging all these creatures and
coming back maybe 150 years later to see how long they've all lived, it's just really, really tricky
science. It's going to require huge projects that span decades or maybe even centuries.
So I think that ageing is a far less universal phenomenon than we think based on the fact that
a lot of the mammals that we experience in everyday life seem to show this phenomenon.
So what's going on in their biology that will allow us to try and slow down our own ageing
process? It's all very well finding these animals that do this stuff. Going back to this question
of what is ageing, I think you can see that on the slide behind me, I've cheated. And the way in which
I've cheated is that every single one of those things is a massive category. Think about cancer.
There are hundreds of different kinds of cancer. Think about memory loss. There are so many
different processes that could go wrong in your brain that could cause you to lose your memory as
you get older. These things are huge categories of stuff. If I really write out what's actually on
this slide, it'll be in size one, it'll be bigger than the whole wall of the lecture theatre, and it
would take me a whole evening just to read through all those different things. And the other thing is
the way modern medicine approaches these ideas is it treats them very much in silos. So if you get
cancer, you might find a lump, you might go to your GP, your GP will send you to an oncologist,
a cancer doctor, they'll give you some chemo and radiotherapy, maybe the cure is the cancer,
maybe it doesn't. That oncologist will pay very little attention to the wider problems that you've
got in your body. They won't be worrying about your dementia, they won't be worrying about your
slight amount of heart disease. And this has a consequence that we end up fighting these fires,
these things are the end consequences of the ageing process, but we don't attack the problem
at its root cause. And just to really illustrate just how significant our lack of ambition is here,
if you were to completely cure cancer, literally if I were to tell you I've got this injection,
no one will ever die of cancer again, it would only add three years to human life expectancy.
And the reason is that something else will be waiting in the wings to kill you. By the time
you're old enough to have been diagnosed with cancer, you've probably got nascent heart disease,
you might have a bit of dementia on the go, there are loads of other things that could be,
you know, just hanging in there waiting to finish you off if the cancer doesn't quite manage it.
So as a result, what we need to do is go after the ageing process itself, I hope I've convinced you.
And that's much more exciting now, because if you were to ask an ageing biologist what is ageing,
they might give you a list that looks something like this. Now I don't expect you to read through
every single part of this and you'll be relieved, anyone with families, that I'm not going to go
through every single one of these before you can go home this evening. But what you can see is this
is a much shorter list, firstly. A lot of these things are categories of sorts, but they're not
as sort of expansive as the category that is cancer. And they're also much more fundamental.
These are the cellular, molecular, biological drivers behind ageing. You know, you could pick
a handful of these and any given age-related disease can be explained by a sort of little
collection of these that go on to cause that disease. And so the idea is that by treating
these particular changes that happen in our biology, maybe we can try and reduce the risk of
many, perhaps even all of those age-related diseases at the same time. Now in order to try and make that
a bit more concrete, as I say, rather than going through the whole list, I'm just going to pick a
couple and explain to you how it is that we could potentially treat these things.
What happens as you get older and how it is you could potentially treat them. So I'm going to start
with something that I very often get asked about when you say you've written a book on ageing biology.
A lot of people say, has that got something to do with telomeres? And the answer is maybe.
So firstly, we're going to start with what are telomeres. This is a beautiful picture.
Can you just take the lights down a bit because there's some beautiful blue there that you can't
quite see. That blue is staining of our DNA. They're the chromosomes. This is where all your
all your genetic information is stored. And it's been tagged with a fluorescent dye. That means
under the microscope it glows. So you can just about make those out, I think, now. And the red
and the green bits are the ends of the chromosomes. So this is another part called the telomeres.
These are the bits on the end of your chromosomes. And if we were to zoom in, then it would look
something like this. You might know that DNA is made up of four letters, so-called base pairs,
or so-called bases, I should say. And the telomere is just this incredibly long,
repeated sequence. It's just TTAGGG, TTAGGG, TTAGGG, as far as the eye can see, hundreds or
thousands of times. You can move the lights back up, by the way. It's not any more beautiful
microscope pictures now. The question is why has our biology engineered it such that we have this
seeming repeated nonsense on the end of our chromosomes? And the answer is, it's to solve
a fairly ridiculous biological problem. So when your cells divide, your DNA has to duplicate in
order to make sure that both of the daughter cells that are produced from the division have a full
copy of your DNA, because that DNA is the instruction manual that tells the cells how they
work, so they need all of it. But when your DNA is copied, you can imagine it like a builder trying
to build a wall, but she's standing on the wall that she's building. So she puts down a brick
here, then she moves along, puts down a brick here, moves along, puts down a brick here. When
she gets to the end of the wall, she can't place the brick where she's standing, and that means
inevitably there's going to be, you know, DNA is a double-stranded, double helix. There's going to
be a single-stranded bit of DNA sort of dangling at the end. And evolution has never come up with
a better strategy to replicate our DNA than that, because it came up with a kludge to solve the
problem. And that kludge is telomeres. Rather than having essential genetic information that you'd be
very sorry to lose on the end of your chromosomes, instead you have this repeated nonsense. And say
you lose, you know, a few tens or hundreds of bases of this TTAGGG repeat sequence, then, you
have no real hard feelings, it doesn't really have any impact on your biology, and that sort of
solves the problem. It papers over the cracks, as it were. But as you can imagine, this isn't really
a very long-term reprieve from this particular problem, because eventually, as you get older,
your cells in your body, in a lot of places, they're dividing all the time. So if you think
about your skin or the lining of your guts, these are pretty sort of nasty environments. You know,
you're exposed to the external environment, all the rubbish that you eat, and these cells, therefore,
basically they've evolved to be disposable. And they're replaced by stem cells that divide,
and then constantly renew the outside of these tissues. They're called renewal tissues.
And that means that, as you get older, the telomeres of these stem cells get shorter and
shorter and shorter and shorter, until eventually you essentially run out of telomere. Now, that all
sounds well and good in terms of the cell biology of it. That's the thing that you can observe in
cells in a dish, their telomeres do get shorter. This would actually matter in full-size human
beings. It's always a question you should ask yourself when, you know, somebody tells you some
results or something in the lab. So let's have a little look at a picture. I love grass with age
along the bottom. This is a sort of recurring theme here. But this time, instead of chance of
death, we've got the length of your telomeres in bases. So this is, as I say, those chemical
letters the DNA is made of. And the graph looks something like this. And that's what we in science
call not a great correlation. You can see that there is a sort of pattern going there. But there
are some 20-somethings who have shorter telomeres than some lucky 90-somethings. And you've got to
ask, who is this guy? Is telomere Wolverine? It's probably actually an experimental artifact, of
course. But what you can see is this isn't the greatest way to determine someone's age. We've
already got a technology that can do that rather more accurately. It's called birth certificates.
Nonetheless, there is a correlation there. And if you draw a line through, you can see that
that's the equation. So it's about your telomeres by this unit of measurement start about 5,000
letters long. And then every year or so, they subtract about 17 or 18 of those bases. And so
gradually over your lifetime, they go from quite long to a little bit shorter. And that's, as I
say, a fine correlation, but it's never going to measure up to birth certificates. However, there
is definitely something going on here. And the reason we can say that is we've done experiments
looking at people who have longer and shorter telomeres for their age. And if you have short
telomeres for your age, it tends to mean that you're predisposed to various different diseases,
things like diabetes and cancer and so on. It also tends to mean that you're more likely to die. So
there have been these rather morbid studies. So you get identical twins. So they've obviously got
identical genetics. They're probably brought up in quite a similar environment. But you find that
the twin who has the shorter telomeres is more likely to die before the twin who has the longer
telomeres. So there's definitely something going on in this biology. And again, you might think this
is just me delivering bad news. All of our telomeres are shortening, as you listen to me right now.
The good news is there is something that we can do about it. And that comes in the form of an
enzyme called telomerase. Telomerase is something that exists to extend those TTAGGG repeats. And
it's really, really important. Because if you think about it, when you have a baby, you don't
want that baby to be born with stubby, short telomeres from middle-aged you. You want it to
have lovely, long, fresh telomeres. So there are certain scenarios in the body where we activate
this gene and extend those telomeres. The question is, why doesn't evolution just leave telomerase on
all the time? You know, why in most of our adult cells is there no active telomerase?
And so therefore, you know, we thought maybe we could just turn this thing on and it would
basically be an immortality enzyme. And I remember back when I was at school in the 90s watching a
Horizon documentary basically touting telomerase as the solution to our mortality. But of course,
scientists hate this sort of hype, and particularly when it's got a cynical problem at its core.
And that problem is, the reason that our bodies don't activate telomerase all the time is cancer.
So if you can think about, you know, what would happen if our cells could divide indefinitely?
Well, there's a disease that involves cells dividing indefinitely, and it is, of course,
cancer. So by having telomerase activated in all of your cells, that massively increases the risk
of cancer. It doesn't cause cancer as such, but it sort of pre-ticks a box on cancer's list because
it means the cells have that capacity to divide indefinitely. And therefore, it's a really bad
idea. And this was actually reiterated by doing some mouse experiments. So if you get a mouse and
you give it some telomerase, the way that you do that is that you inject some genes into the very
early embryo. It's called germline gene editing. So you add an extra copy of telomerase, what
happens? Well, the mice basically all get cancer, which is really, it's bad news. And I think also,
it was really bad news for the idea of telomerase because scientists love to latch onto one of these
cynical narratives, had this supposed immortality enzyme that got a load of hype, turns out it just
causes cancer, nature's a double-edged sword, isn't that a horrible irony? And the field really
sort of collapsed a bit in the early 2000s when these results came out. But thankfully, some
scientists did persist. And I think, you know, something that's worth thinking about with this is another
reason I think scientists were cynical is because you think about evolution. And the reason that you
think about evolution in this context is evolution has clearly made that decision to turn off telomerase
in as much as evolution decides anything, but let's skip over that for the moment. It's made
that decision because it realises that the risk of having telomerase activated is higher than the
benefit from having activated. And there's this very well-known phrase that evolution is cleverer
than you are because evolution has had millions, maybe even billions of years to optimise the
various processes going on inside ourselves. And what that means is you as a naive scientist go and
stick in some telomerase. Well, of course you're going to mess things up because evolution's
optimised them very carefully. So in 2008, there was a paper published where scientists did something
still naive, but slightly less naive, which was that they added, they got a mouse and they did
another of these germline modifications. They added telomerase, but they also added three other genes,
p53, p16 and R, if I'm not going to talk about exactly what those do. Basically, these are
anti-cancer genes. They're genes that keep an eye on the genome inside the cell. And if there's any
problems in the DNA that might predispose that cell to becoming cancerous, what they do is they
shut that cell down. They either convince the cell to commit suicide in a process called apoptosis,
or they turn that cell into a non-dividing senescent cell. Hold that thought, we'll be
coming back to that in a second. But nonetheless, that puts the brakes on cancer. Either the cell's
dead or it stopped dividing so it can't turn into a tumour. And it turns out that by adding this
combination of genes, you actually can extend mouse lifespan by about 40%. And they didn't seem
to have any increased risk of cancer compared to a normal mouse. So that's a really incredible
result. And it sort of blows a hole in the idea that evolution is cleverer than you are.
The reason, I think, is probably that evolution still is cleverer than you are. It's just
optimising for something that you aren't optimising for. Evolution is optimising for reproduction. It
wants mice that can churn out as many babies as possible, have, you know, successfully pass on
their genes. But what we might be optimising for is health or length of life or something like that.
And if you want to have something different from what evolution is optimised for, even relatively
naive interventions like this seem to have some level of success. So although people might tell
you that ageing is a really complicated process, we've actually got one up on evolution because
evolution didn't optimise for animals necessarily that would live a long time. And then there's also
optimistic news for those of us in the audience who have already been born because we don't want
to have a treatment that's only applicable to tiny little embryos. Some scientists, the same
scientists in fact, gave temporary copies of telomerase and they did this to adult mice.
So rather than giving a gene that's always activated, they gave it in a form where it would
pop into the cell, turn on the telomerase, lengthen those telomeres for a bit but then
that telomerase gene would get degraded so it would disappear out. And so that extended those
mouse telomeres and again it gave them 20% longer life and no seeming increased risk of cancer.
And this is a treatment that was done in adult mice. It was given to mice that are about a year
old and obviously mice age much faster than humans do. So that's about sort of 40, sort of early
middle age in human years. So there's, you know, there's hope for most of us in this audience yet
because these treatments can be applied before, you know, after you're a baby and nonetheless have
an effect on your lifespan and have an effect on how healthily you live as well. So I think this
really shows, it's just a really fascinating story of something that was touted initially
as an immortality enzyme, had this sort of obvious cynically exploitable dark side, but now
thankfully has these prospects where telomerase and telomeres may actually be a more exciting
prospect when it comes to ageing as well. I thought, so that's one of the hallmarks. I've
shown you how telomeres get shorter with time and we can extend them to try and fix them.
I thought I'd also mention senescent cells and I already brought those up and said that
this is something that you should hold that thought and we'll return to. The reason is that senescent
cells, these are cells that are aged. We already learned the word senescence in negligible senescence
earlier in the talk. These are cells that accumulate in all of our bodies as we get older
and they're cells that have stopped dividing as I mentioned just now. So they're cells that for
various reasons, either they've got a lot of DNA damage or their telomeres have got critically short
and the body puts on the brakes. It says to that cell you're not going to divide anymore
and the reason that the body does that, as we've already discussed, is it's an anti-cancer mechanism
and when you're young that works really well because the senescent cell sends out this whole
bunch of signals and it says, hey I'm over here, I'm senescent, immune system, come and gobble me up
and an obliging immune cell will wander over, gobble up the senescent cell and all is well
with the world. The problem is that as you get older there are more rapid processes producing
these senescent cells. Your DNA has got more damage in it, your telomeres are getting shorter and so
on, so the production side is ramping up. At the same time your immune system is getting weaker
because you're aging for a variety of reasons, one of which actually is some of your immune
cells going senescent, there's a sort of vicious circle going on and so these senescent cells start
to accumulate and the bad news is that that sort of cocktail of molecules that the senescent
cells are emitting don't just attract over the immune system, they seem to accelerate the whole
of the aging process. So unfortunately as you accumulate these senescent cells it accelerates
your aging in a whole variety of different ways and actually ironically those secreted molecules
can even at high enough concentrations increase the risk of cancer, so they even sort of go counter
to the very purpose evolution we originally engineered the cell type for. So that's the bad
news. The good news is we have drugs called senolytic drugs and these are drugs that can go
in and kill the senescent cells while leaving the rest of the cells of the body intact and there are
some really exciting mouse results relating to these drugs. So in 2018 there was a paper published
where they gave these senolytic drugs to a bunch of mice that were 24 months old now, so again mice
aging faster than us that's sort of 60, 70 years old in human years, these are quite old mice and
it basically made them biologically younger. So the first thing is they lived a bit longer, that's
good news, but they didn't just sort of stretch out the frail period at the end of life and have
them staggering on unable to summon the energy even to die, they lived healthier as well, they got
less cancer, they got less heart disease, it wasn't just diseases, they were less frail, they were
able to run further and faster on the tiny little mouse treadmills they use in these experiments,
they had improved cognition, so if you put a young mouse in a maze then what you find is it's very
exploratory, it's very excited to explore this new environment. If you put an older mouse in a maze
it's often a bit more anxious, maybe it's just a bit lazy because it's you know not quite so
physically capable and by deleting these senescent cells you actually restored some of that youthful
curiosity and finally these mice just look fantastic. I'm a computational biologist so I've
never been in a biology lab, I don't know which end you hold up a pet from, but nonetheless even to my
wildly untrained eye, mice that have had these senolytic treatments they look great, they've got
thicker plumper fur, they've got nicer skin, they just look fantastic, they look younger and so what
this really shows us is that these senescent cells, they are a hallmark of ageing, they want
something that accumulates with time and by getting rid of them you can slow down, perhaps even reverse
the ageing process, not just a single disease, this isn't like a prevention for a single thing,
it seems to be for many, maybe even all aspects of the ageing process, so that's a really fascinating
thing and I think you know something has the potential to be the sort of holy grail, sort of
to show us how ageing treatments should work, you want to get something you can give to an older
person, you can reverse or change one of those hallmarks back to a younger state and then you
can increase their lifespan, their health span most importantly, so the time they spend in good
health in a variety of different ways, you can prevent not just one disease but maybe even the
whole smorgasbord of diseases and that's why I think this has got the potential to be a revolution
on a par with antibiotics, because in exactly the same way as a single antibiotic can treat a whole
range of bacterial infections, so too a single anti-ageing drug should be able to prevent, not
just treat, but actually prevent a whole range, maybe even all of the symptoms of ageing, you know
even the cosmetic stuff, I think you know it's relatively likely that we'll go after something
that's a bit more serious and the patients will come back and say, wow my hair's growing back,
this is fantastic and then you'll get a load of patients going, oh my knee's a bit dodgy doctor,
can you give me some of those senolytic drugs please, just in order to try and you know get
access to those cosmetic benefits at the same time, because fundamentally all of these things
are driven by the same ageing process, the same underlying hallmarks, so senolytics are a super
cool idea right, but there's there's a slight problem to their adoption and that problem is
that currently they're only being explored for specific diseases where we know that senescent
cells are a problem and the place that that might start is something like, there's a disease called
idiopathic pulmonary fibrosis, lung fibrosis, if you want slightly less of a mouthful, it's where
your lung tissue starts to scar and this often is a very age-related disease and it happens much
more commonly in older people and it's basically irreversible and it's a disease with a very poor
prognosis and we think that senescent cells are involved in this scarring process and so this is
one of the areas that you know one of the first places where human trials are going to start
and that's that's exciting because you know hopefully it could give a treatment prospect
for people who haven't really got one with this disease currently, but obviously it's not handing
these things out preventatively for the whole ageing process and the first thing we want to see
is some convincing human data for these more specific conditions, we want to see that they're
clearing the senescent cells, we want to see that they're improving the prognosis of patients with
these specific senescent cell associated diseases, but most importantly we want to see that the drugs
are safe because if you've got IPF then you're in a position where you've got quite a serious disease,
there are no real effective treatments at the moment so you're willing to take a bit of a punt
on what is still you know frankly a treatment that's been shown to work in mice but otherwise
is quite experimental, whereas would I take a senolytic now, would I take a senolytic if I'm 60,
I'm not really sure, we want to see a bit more human data and particularly we want to make sure
they're very very safe and they don't have any serious side effects, and the other problem
beyond that is that there's just no way to get a regulatory approval and that's because the way
that medical regulators approve drugs at the moment is they're traditionally approved to
something called a specific indication, that's just sort of pharmaceutical regulated jargon for
a condition or a disease and that means you know you can get a drug approved for treating cancer
or for preventing heart disease but can you get a drug approved that you're going to use to prevent
aging, we're going to give it to people who would currently by the medical system perhaps be
classified as healthy and we're going to use it for some kind of preventative nebulous thing, well
there's another drug that's actually blazing the trail for what I think are probably the more
exciting drugs like senolytics and this is a totally revolutionary trial of a thoroughly
un-revolutionary drug, it's a drug called metformin, this is a drug that actually you know some people
in here are probably taking, it's certainly a drug that almost all of you will have a friend or a
relative who's taking, it's a very very common diabetes medication, it's one of the most commonly
prescribed drugs in the world, there are over 80 million prescriptions a year written in the US,
in the UK we've been prescribing it since the 1950s so it's got this incredibly long safety
profile, we know it's a really safe drug, but what's quite exciting about metformin is that we
think it might be able to have an effect not just on diabetes but on the aging process itself
and this first came out in a study in the last decade or so where again we've got time in years
this time rather than age on the bottom, so this is the time since the study started and we've got
survival up the right hand side so I'm going to show you something called a survival curve
and this was a retrospective study looking back at people's NHS medical records
and the main purpose of the study was to look at the difference between a class of
diabetes drug called sulfonylureas and what you can see is thankfully that's a 75 down there at
the bottom so not everyone was dead after five years, but you can see that that's the sort of
rate at which people were dying, so that's a sulfonylurea treatment, if instead you treat the
patients with metformin you can see that's a much better survival curve, there are far more people
alive at the end of this particular sort of retrospective experiment, so that's a point you
know if you're a diabetic that's why metformin is the first line treatment, however as a what's
called a control group, so a group who are sort of acting as a statistical control to understand
what's going on with the drug here, they also included some people who weren't taking metformin
and the reason they weren't taking metformin is because they were non-diabetic, now what's
interesting about that is that if you're not diabetic you're often much healthier in a lot
of ways than someone who is diabetic, you probably have a bit less, carrying a bit less weight,
you've probably got less heart problems, there are various other things that sort of come along with
diabetes and then obviously you're not taking the metformin, however their survival curve looked a
bit like this and what's really interesting is they seem to be dying at a more rapid rate than
the diabetics who are taking metformin, so the question is, is this because metformin has some
kind of anti-aging effect? Now we've got to be careful because this is an observational study as
it's called, so we're looking at people out in the world, we're not actually intervening in any way,
so the problem is there could be some kind of confounding factor, an example of that is that
maybe if you've got diabetes you just go to your doctor more often, because you've got diabetes
it's being monitored, you pop in, if you get high blood pressure or something else goes wrong with
you, you've got a regular visit with your GP scheduled and so they might spot it a bit earlier,
so maybe that's one of the reasons that patients on metformin live longer, rather than it being
intrinsic to the drug itself, so what we really want ideally is a randomised controlled trial,
so a drug trial where people are randomised into one group, they either take metformin or not at
random, and then we can see if it's the drug itself that's having the effect rather than something
else about those individuals, and that is the purpose of the TAME trial that was supposed to
start actually a few years ago, but Covid, and hopefully will be starting at some point soon in
the US, it stands for Targeting Aging with Metformin, you can see it's an American trial
because they spell aging wrong, and the idea behind this trial is they're going to get 3,000 people
and they're going to give half of them metformin and half of them a placebo,
so it's a drug, you know, a pill that basically doesn't do anything, and they're going to watch
them for 3 to 5 years, and what's really interesting about this trial is they're not
going to look, they're actually explicitly not looking for whether or not it prevents diabetes,
but they're going to look at whether it prevents a whole range of other age-related issues, things
like dementia and cancer and so on, obviously whether people die is another really, really
good indicator, and if they find that the people who are in the treatment group, so they're getting
the metformin, are dying and getting these diseases at a lower rate than people who are in the control
groups who aren't getting metformin, then what they'll hopefully have demonstrated is that
metformin slows down the aging process itself, and this whole trial protocol has been developed
in collaboration with the FDA, the Food and Drugs Administration in the US, who are the regulator
of medicines, and what that means is this is a pathway which will allow future medications
potentially that are treating aging to sort of follow that same trial design, so they've designed
this, this isn't a thing that's normally done, normally clinical trials are done, then you take
the results to the FDA, but they've developed the protocol in collaboration with them in order to
lay this groundwork. Now this, that's the reason this trial is revolutionary, because it could open
up a whole new class of, you know, ability to regulate and approve drugs. The reason it's not
revolutionary is firstly, as I said earlier, metformin is this really, really widely prescribed
drug. Second reason is if we go back to this graph, you can see the difference between the
metformin and the non-metformin groups, not very much, like maybe six months, could you make that a
year if you squint? So we're not expecting that metformin is going to suddenly make us all immortal,
in fact, you know, it might not have any effect on life expectancy, that's the whole point of doing
a trial. But the reason it's been chosen is because it's, it's a, you know, it's basically
a safe pair of hands. We've been prescribing this thing for so long, we know it doesn't have any
really serious side effects. I think perhaps one of the most important things that the first trial
of a real anti-aging drug can do is not, you know, make people grow a third arm or something,
which is going to completely destroy the field of 20 years. So the idea is this is a nice safe
option, it probably isn't going to transform the world, but if it does make a difference, or even
if it doesn't make a difference, in fact, it's going to lay the groundwork for those future and
potentially more exciting drugs. So that is the TAME trial. And if we go back to these hallmarks,
I think what's really, really exciting is that we've got so many different ideas. So you see
there are 10 things on this list, we've got multiple ideas for treatments that address each
of these hallmarks of aging. And that means that even if metformin doesn't work, even if senolytics
don't work, even if telomerase doesn't work, we've got loads and loads of other things, it'll be like
bafflingly unlucky if literally none of our ideas are successful. And what that means is that we've
got loads of opportunities to give people longer, healthier lives. And what I sometimes talk about,
you know, if we're going to think a little bit further into the future here, I sometimes like to
talk about a cure for aging. Now this sort of raises the hackles of some scientists, it's a bit
of a bizarre sounding concept. But actually, I think this is really what we should be aiming for.
Because all I mean by a cure for aging isn't some sort of wacky sci-fi nonsense. It's a risk of death
that doesn't change with how long ago we were born. And we've already seen that that's a biological
possibility. There are loads of different animals that have this negligible senescence property.
And although it might not necessarily happen soon, I guess we'll have to see. Depends how lucky we get
with these various treatments. There's no biological reason it's not possible. And from an ethical
standpoint, we'll get into a few more of those questions in a moment, but it just seems completely
inarguable. It's the ultimate goal of modern medicine. We want to try and reduce suffering to the
lowest possible level. We want to reduce the incidence of all these different diseases. And so this
is something that really, really excites me. When I talk about a cure for aging, I think a lot of
people imagine a single miracle pill that's going to, you know, some lone genius is going to invent
some magic thing and we'll just pop it and live forever. That isn't what this is going to look like.
Firstly, you won't live forever because you'll still be able to get hit by buses or get whatever
the next pandemic is, and that could kill you. And secondly, it's not going to be a single pill
because there are loads and loads of different things going on here. I think we're going to
require treatments for multiple of the hallmarks of aging, maybe even all of them. There might even
be other things that we add to this list. What's kind of exciting is that our first really naive
attempts where you just try and add a bit of telomerase or, you know, delete senescent cells
do seem to have quite wide ranging effects. So there's a little bit of hope that we don't have
to understand the whole process. But I feel like once we start to target multiple of these hallmarks,
firstly, we're going to be on a much better path towards developing treatments. And secondly,
it'll help us to understand scientifically which of these hallmarks are the most significant and
how they're all connected to each other. I think that's ultimately what we're going to need if we
want to cure aging, is to understand sort of the complex ways in which all of these different things
are interdependent one another. So why should we be aiming for it? Well, I hope I've convinced you
from the first part of the talk, this is our greatest humanitarian challenge. It's inarguably
the largest cause of death. It's, I would say, almost certainly the world's largest cause of
suffering unless you've got some other contenders. And every single day that we bring forward a cure
for aging by saves 100,000 lives. Now, you might not be too worried about your own death. But I
think it's, I'm surprised sometimes by how controversial this is. But I do think death
is bad. And a world in which there was a bit less death would be a better world. So you know,
we can argue exactly how long human life expectancy should be. That's a fascinating question. But I
think in general, reducing death from the level it's at at the moment would probably be a good thing.
And this is a hard goal, right? This is something that's going to be a real challenge for us to
implement. It's going to require a huge, huge amount of biology, it's going to require us to
uncover all of these, you know, how all these hallmarks work and how they're all connected.
But it's not an impossible task, because we've already seen these analytics that are already in
development. There are 20 or 30 companies now trying to turn analytics from an idea in the lab
to something that actually works in humans. It's not at all inconceivable that the first anti-aging
drug could be with us in the next decade. And that means that most people, again, in most countries
are going to live long enough to see the fruition of this work. And if you live long enough to take
the first analytic, then perhaps you'll live long enough to take the next round of anti-aging drugs.
And that gives scientists even more time to develop the next more effective round of anti-aging drugs
and so on. So if you can keep yourself healthy and alive for as long as possible, this is a
really, really cool time scientifically, you know, to be a human being. So that's my sort of positive
case for why we should do something about aging. The next question is, should we cure aging? And
I think, as you can probably tell, the answer is an unequivocal yes, but I have discovered from
talking to audiences that that is not a universally held belief. And actually, you know, it's a long
time since I was first confronted with these ideas. I've had basically a decade to really digest and
grapple with all of this stuff. But I think when you're confronted with it fresh, it sounds weird,
it sounds sci-fi, it sounds a bit kooky. And actually, sci-fi has done us a terrible disservice.
All of the situations in which, you know, immortality is dealt with or longer lives, they're usually
dystopias. They're usually, you know, billionaires living forever and there's some underclass who are
in mortal servitude to them or something. And so it's very easy to think that curing aging might
have loads of terrible moral consequences. Now, I actually think the moral case is completely
watertight and I haven't got time to go into every single nuance of it here. But I'm just going to go
through one example to sort of give a flavour of why I think this is such a powerful case.
And that's probably the question I get asked most commonly is, what are we going to do with all the
people? Because, you know, if people are living longer lives, then they're going to increase the
strain on the planet, we're going to increase resource use, we've already got problems with
climate change and air pollution and all kinds of other stuff. And actually, you know, I should say,
I'm pretty worried about this too, because I, when I was contemplating my life at the end of my
physics PhD, I nearly became a climate physicist, because I thought that might be a way to have a
big impact on the world, and eventually decided that actually aging was a more pressing concern
that had fewer people working on it. Nonetheless, this is something very close to my heart.
So what about overpopulation, as people often sort of pose the question? And let's have a look at
what happened to population in the last, say, 20 years. So along the bottom this time, we've got a
different sort of time, years rather than age. And up the side, we've got how many people there are in
the world. In 1999, the population just exceeded 6 billion. I think in 2011, we exceeded 7. We're
coming up on 8 billion people now. But obviously, the real question is what's going to happen in
the future. And one of the most popular population projections is made by the UN. This is the UN's
medium variant. And they predict that by 2050, we're going to have about 9.7 billion people. So
that's the best guess by the United Nations. Other guesses are available. But I'm just going to run
with this one for now. So what would happen if we were to do something about aging? Well, I thought
I'm not a demographer. I'm in no way an expert in population modeling. What I can do is something
really, really simple. I can cure aging in 2025, statistically, of course, not in real life. And
what that means is that people will stop dying of old age. People will reach a certain age, and
they'll just die at the same rate as they did every year before that. And if you literally cure aging
in 2025, now I'd like to just emphasize, this is ridiculous, right? Because not only is that a
ridiculous timescale scientifically to solve this problem, it's also a ridiculous timescale from a
economic and social standpoint. We have to roll out these drugs universally in the next two,
three, four years. Absolutely crazy. But as a population pessimist, you could see this as the
worst case scenario, because this is a ridiculous extreme. And if we cured aging in 2025, population
would look something like this. So by 2050, the population would be 11.3 billion. Now, that is
more. It's almost 2 billion more people. In percentage terms, it's not quite so much more.
It's about 16%. Now, that's not nothing. I don't want to have to work a little bit harder in order
to solve all of these global problems. But then you've got to think about what's on the other
side of the equation. I want to fight climate change. I want to fight all these different
forms of pollution, you know, ways in which we're destroying the Earth's natural environment. But I
would happily work 16% harder to achieve those goals if it meant that we could suddenly effectively
stop people dying of old age. We could stop the cancer. We could stop the heart disease. We could
stop the dementia. I just find that a much, much more compelling argument. And actually, there's
something else that we need to consider here. Not only is this a relatively small change, it's also
actually smaller than many other changes that we have to think about. So the UN also produced a low
and a high variant. And the difference between these is nothing to do with life expectancy.
It's really fascinating just how uninterested demographers are in life expectancy. They think
it's basically going to plateau about where we are now, which is a bizarre expectation. But the
difference between the low and the high variant is actually larger. It's 19% than the difference
between if we literally cured death and if we didn't. Sorry, if we cured aging, I should say,
not death. And that's just staggering. A small and relatively expectable change in birth rates
is going to have a larger effect than this ridiculous assumption that I've made about
people not dying of old age anymore. And obviously what's really going to happen is we're going to
develop these treatments more slowly. They won't be rolled out quite so fast. So the problem that
we're going to have to confront is going to be smaller still. So I really think just on the face
of it, it's not going to be as large a problem as it sounds like it should be. And actually, if you
look outside the UN's projections, there are other very serious demography outfits who think we're
facing an underpopulation crisis. So if you're a real sort of techno future optimist, it could be
that a cure for aging saves us from an underpopulation crisis in the second half of the century.
So demography is hard, basically. And I think the real lesson that this teaches us is that
when you're thinking about these questions, I think the most powerful way to answer any ethical
objection to aging is to reverse the question. That's to imagine that we live, and let's take
the population examples again to run with it. Imagine that we lived in a world where aging
didn't exist. People were living much, much longer lives. They were living in good health. People
still die. They still, as I say, get hit by buses, get infectious diseases. Even young people get
cancer just at a much, much lower rate. But we're living much longer, healthier lives. But imagine
we were confronting that overpopulation crisis. There was this terrible toll on the environment.
We were polluting everything. There was huge, huge climate change going on. How would you try
and address that problem? Well, I think first of all, you should try and reduce our carbon footprint.
You should change the food that we eat. We can reduce our land footprint by a huge amount just
by switching to a slightly more vegetable-based diet and so on and so on. If you tried all of
those different things and none of them were working, the only thing that you had, and I should
suggest this is a very sort of last resort option, was to kill people, then would you really do it
by inventing aging, like this decades-long process of horrible decline? I think if you absolutely
had to kill people, and as I say, last resort, I'd rather do it in a brief, painless way rather
than dragging it out over that extended period. I think if you try and approach any potential
objection to treating aging from a moral standpoint, think about people often ask,
won't dictators live forever? Would you create aging to kill one dictator but condemn all of
their subjects to decades of suffering, perhaps even worse than the dictator's doing already?
If people say, wouldn't I get bored with my extended lifespan? Would you age to death rather
than get bored? It's absolutely incredible. I think by reversing the question, it's absolutely
morally repugnant to invent aging. I think therefore it's equally morally repugnant to
allow aging to continue to exist to solve some perceived problem with the world.
I just think, therefore, there's this huge, compelling, morally watertight case.
This next slide, this is actually really why I wrote the book that I wrote. This is because I
think not only is there a huge moral case, which is sort of the driving factor, I want to make the
economic case now. We're going to look at the cost of these chronic diseases. These are diseases
that are, as I say, essentially caused by the aging process. This is cost to the United States.
It's got some figures that are much easier to get at, which I'll explain why in a second.
Cancer costs them $280 billion a year. Heart disease costs $200 billion a year. Stroke,
$110 billion a year. Dementia, $270 billion a year. This is the total cost of the economy. It's
the healthcare. It's the people having to give up work because they're ill. It's the people caring
for them and that sort of stuff, all combined together. If you add those up in your head,
that's getting on for a trillion dollars. That's just some of the diseases of aging.
The total cost of the US healthcare system is over $4 trillion. That's an incredibly incredible
amount of money. Yet, even though a huge amount of that healthcare expenditure and a huge amount
of other economic costs as well are caused by the aging process, this is the budget for the NIA,
the National Institute of Aging. This is the reason I chose the US, by the way, because the
US is one of the few countries in the world that even has research institutes dedicated to funding
aging research. That little square isn't just a style feature. It's in proportion to the size of
the amount of money that's spent, $3.5 billion, which compared to that, almost a trillion dollars,
almost a thousand billion, is just peanuts. Actually, it's even worse than that because
there's a running joke in aging biology that NIA doesn't stand for National Institute on Aging,
but for National Institute on Alzheimer's Disease, because if you break that budget down, then about
$2 billion of it goes to NIA's neuroscience division. This is the part of the NIA that
basically looks into dementia. Then you've got another billion or so on other NIA activities.
They do a lot of social gerontology about phenomena around getting old from a social perspective and
various other biology. Then when you drill down to the bit that's actually on aging biology,
actually trying to understand the processes that give rise to this huge, huge cost,
it's about $350 million. That's a bit over a dollar per American, even though in America,
they spend about $17,000 per person on healthcare. As I say, a huge amount of that is caused by the
aging process. Even just on a raw economic basis, if you think this research has any chance of
success at all, then you should be investing far, far more than a dollar per person in trying to do
something about it. Actually, if you break down the huge benefits to society, there was a paper
that came out last year that tried to look at the benefits, again, to the US. Things are often
done because obviously they're the world's largest economy, fighting out with China, I guess, but
for the moment, still the world's largest economy, I believe. What they found was that the benefit
to delaying aging by a single year, so keeping people healthy and allowing them to die that
single year later, was $37 trillion. Again, not million, not billion, trillions. That's 12 zeros.
It's an incredible amount of money, the benefit to all of those people. As you keep on scaling
that up, if you go up to adding 10 years of life, that scales almost linearly. I think it was $367
billion was the benefit of adding those extra years of life. There's really huge, huge amounts
of money on the table. The money that we save in healthcare, by the way, we could then spend
on solving some of those problems like climate change that I and many others are worried about.
There's this huge, above and beyond the moral case, there's this huge economic one as well.
We just need to massively increase the numbers on the right-hand side of this picture because
if we invest in that research, then we can work our way through those hallmarks of aging. We can
start to develop some treatments. That is, as I say, why I wrote this book, because I realised that
this just isn't something that people are very familiar with, whether it's members of the public.
I want people to be going out and talking about aging biology in the pub. I want it to be a
topic of political, social importance, rather than just being this weird, kooky bit of science.
It's also really important for politicians and policymakers, because obviously those are the
people who ultimately hold the purse strings. They're answerable to the public, which is why
it's so important that the public understand this as well. I also wrote this book for
scientists and for doctors, because I worked for about five years as a computational biologist
before starting writing this book. What I found was that even biologists aren't very familiar
with this stuff, because aging has historically been quite a small field. You end up with this
vicious cycle because there aren't very many people who studied aging, so there aren't very
many professors lecturing in it, so there aren't any PhD programmes that people can then feed through
and become lecturers lecturing in it themselves. There's often not even a page in a textbook about
this most universal process in biology, and a lot of biologists think it's this inevitable process
of wear and tear. I'd met people who had great degrees, great PhDs from great universities,
and I knew more about aging than they did. That isn't because I'm some kind of genius, it's just
because I'd read a few books, and it meant that I was in advance of what they'd learned.
My wife is a doctor, and when I first met her, I think she thought I was crazy talking about all
this wild treating aging stuff. When doctors go into medical school and have their
lectures on aging, it's all about the geriatric side. It's about, are these patients really
complicated, because the average 80-year-old is taking five different kinds of medications, so
you've got to be really careful anything you prescribe to them doesn't interact with their
other medications. They don't have social problems because they're living alone. These are all really
important things for doctors to know, but it's pretty likely that within her career, it's going
to be possible for her to prescribe genuine, actual, working anti-aging drugs, and yet she
knew very, very little about it. Thankfully, as you can see from my wedding ring, I did eventually
convince her. But nonetheless, this is a huge, huge problem, because even the nerds don't know
about this stuff, so we just have to spread the word, get these ideas out there. So if you want
to do that, you can find out more about the book at ageless.link. I'm sure a lot of you still got a
load of ethical questions, because I really skipped over that in a very rapid fashion. There's also a
free chapter on the ethics of aging biology at ageless.link slash ethics. There are some videos
about it on my YouTube channel, and here are some other links about me. Thank you very much,
and I think we've got time for a few questions.
